Showing results (21-30 of 573) with videos related to
Sort By:
Pageof 58
Korean Circulation Journal|January 12, 2018
Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and EvolutionDavide CapodannoInterventional Cardiology Clinics|June 6, 2017
Bioresorbable Scaffolds: Clinical Outcomes and ConsiderationsDavide CapodannoCardiology Journal|January 22, 2020
Mechanisms of ST-segment elevation myocardial infarction in patients with atrial fibrillation, prior stenting and long-standing chronic coronary syndromeAntonio Gabriele Franchina, Dario Calderone, Paolo D'Arrigo, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 22, 2025
Long-term outcomes of percutaneous coronary intervention for recurrent events in patients undergoing target-vessel vs. nontarget-vessel revascularizationSimone Finocchiaro, Maria Sara Mauro, Claudio Laudani, et al.American Heart Journal|March 12, 2011
Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directionsDavide Capodanno, Corrado TamburinoAnnals of Internal Medicine|November 10, 2015
Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysisGiuseppe Andò, Davide CapodannoJACC. Cardiovascular Interventions|January 25, 2020
How to Define Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves: Facts and MisconceptionsDavide Capodanno, Lars SøndergaardExpert Opinion on Drug Safety|January 31, 2022
Anti-inflammatory strategies for atherosclerotic artery diseaseFederica Agnello, Davide CapodannoProgress in Cardiovascular Diseases|February 26, 2026
Prehabilitation in frail patients undergoing cardiac valve interventionLuigi Cutore, Davide CapodannoGiornale Italiano Di Cardiologia (2006)|February 25, 2026
[Factor XI inhibition in atrial fibrillation: where do we stand?]Simona Giubilato, Davide CapodannoPageof 58